HRT Financial LP Has $1.30 Million Stock Holdings in Exponent, Inc. (NASDAQ:EXPO)

Posted by Defense World Staff on May 30th, 2023

HRT Financial LP cut its position in Exponent, Inc. (NASDAQ:EXPO – Get Rating) by 62.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,110 shares of the business services provider’s stock after selling 22,269 shares during the period. HRT Financial LP’s holdings in Exponent were worth $1,299,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Jump Financial LLC raised its holdings in Exponent by 209.4% in the third quarter. Jump Financial LLC now owns 23,826 shares of the business services provider’s stock worth $2,089,000 after purchasing an additional 16,126 shares during the period. Montanaro Asset Management Ltd raised its position in shares of Exponent by 5.1% during the fourth quarter. Montanaro Asset Management Ltd now owns 80,000 shares of the business services provider’s stock worth $7,927,000 after purchasing an additional 3,900 shares during the period. Point72 Hong Kong Ltd acquired a new stake in shares of Exponent during the third quarter worth about $275,000. Atria Investments Inc raised its position in shares of Exponent by 2.3% during the fourth quarter. Atria Investments Inc now owns 19,086 shares of the business services provider’s stock worth $1,891,000 after purchasing an additional 433 shares during the period. Finally, Vanguard Personalized Indexing Management LLC raised its position in shares of Exponent by 17.3% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 3,193 shares of the business services provider’s stock worth $316,000 after purchasing an additional 470 shares during the period. 91.32% of the stock is currently owned by institutional investors and hedge funds.

Exponent Stock Performance

Shares of Exponent stock opened at $91.98 on Tuesday. The business’s 50 day simple moving average is $93.67 and its 200 day simple moving average is $99.21. Exponent, Inc. has a 52-week low of $80.97 and a 52-week high of $112.75. The firm has a market cap of $4.67 billion, a PE ratio of 46.93 and a beta of 0.64.

Exponent (NASDAQ:EXPO – Get Rating) last issued its quarterly earnings results on Thursday, April 27th. The business services provider reported $0.56 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.56. Exponent had a net margin of 19.39% and a return on equity of 30.86%. The firm had revenue of $140.30 million for the quarter, compared to analyst estimates of $127.17 million. During the same period in the previous year, the business earned $0.56 EPS. The company’s revenue was up 19.0% compared to the same quarter last year. As a group, equities research analysts predict that Exponent, Inc. will post 2.1 EPS for the current year.

Exponent Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 23rd. Shareholders of record on Friday, June 9th will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 1.13%. The ex-dividend date of this dividend is Thursday, June 8th. Exponent’s dividend payout ratio (DPR) is 53.06%.

Wall Street Analyst Weigh In

A number of brokerages recently commented on EXPO. StockNews.com began coverage on shares of Exponent in a report on Thursday, May 18th. They set a “hold” rating on the stock. TheStreet lowered shares of Exponent from a “b” rating to a “c+” rating in a report on Wednesday, May 17th.

Insiders Place Their Bets

In other Exponent news, VP Richard Reiss sold 2,841 shares of the business’s stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $89.48, for a total transaction of $254,212.68. Following the transaction, the vice president now owns 5,258 shares of the company’s stock, valued at approximately $470,485.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, VP Joseph Rakow sold 1,388 shares of the business’s stock in a transaction dated Thursday, May 11th. The shares were sold at an average price of $86.59, for a total transaction of $120,186.92. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP Richard Reiss sold 2,841 shares of the business’s stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $89.48, for a total value of $254,212.68. Following the transaction, the vice president now directly owns 5,258 shares in the company, valued at $470,485.84. The disclosure for this sale can be found here. Insiders have sold 5,729 shares of company stock valued at $508,440 in the last 90 days. 2.00% of the stock is currently owned by insiders.

Exponent Profile

(Get Rating)

Exponent, Inc is an engineering and scientific consulting company, which engages in the provision of engineering, scientific, environmental, and health consulting services. It operates through the Engineering and Other Scientific, and Environmental and Health segments. The Engineering and Other Scientific segment includes technical consulting in different practices primarily in engineering.